Stay updated on Phase II Anti-PD1 Epigenetic Therapy Clinical Trial

Sign up to get notified when there's something new on the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The study details page now displays a 403 Forbidden error, blocking access to the content.
    Difference
    0.5%
    Check dated 2026-09-27T01:50:51.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record details, indicating access to the record is blocked. The visible changes consist of the 403 message, header, and footer rather than the study content, signaling an access issue rather than an update to the study data.
    Difference
    21%
    Check dated 2026-09-20T00:54:41.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    The page footer now shows revision v3.6.6, replacing the previous v3.6.5 and signaling a recent update to the record.
    Difference
    0.0%
    Check dated 2026-08-29T20:07:35.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.6.5, indicating a newer version of the site template or content management update.
    Difference
    0.0%
    Check dated 2026-08-08T16:59:36.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    The site revision has been updated to v3.6.4, indicating a deployment update. No study data or page content is affected by this change.
    Difference
    0.0%
    Check dated 2026-07-25T09:31:25.000Z thumbnail image
  7. Check
    95 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.6.2 to v3.6.3, indicating a minor site revision. This change reflects an update to the page's version tag rather than any alteration to the study content or details.
    Difference
    0.0%
    Check dated 2026-07-03T22:36:34.000Z thumbnail image

Stay in the know with updates to Phase II Anti-PD1 Epigenetic Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page.